Induction of tumour rejection by B7.1 and IL-2 expressing tumour cells

Induction of tumour rejection by B7.1 and IL-2 expressing tumour cells

Detalhes bibliográficos
Main Authors:	Gaken, J, Hirst, W, Darling, D, GaleaLauri, J, Buggins, A, Kuiper, M, Souberbielle, B, Towner, P, Hollingsworth, S, Mufti, G, Farzaneh, F
Formato:	Journal article
Publicado em:	1997

Registos relacionados

Induction of tumour rejection by autologous and allogeneic tumour cells expressing B7.1 and IL-2.
Por: Hirst, W, et al.
Publicado em: (1996)

Tumour cells expressing B7.1 costimulatory molecule: Are these better targets for NK cells?
Por: GaleaLauri, J, et al.
Publicado em: (1996)

In vitro immune modulation by antibodies coupled to tumour cells.
Por: Darling, D, et al.
Publicado em: (1997)

Irradiated NC adenocarcinoma cells transduced with both B7.1 and interleukin-2 induce CD4+-mediated rejection of established tumors.
Por: Gaken, J, et al.
Publicado em: (1997)

A polycistronic retroviral vector encoding hB7-1 (CD80) and hIL-2 for ex vivo cancer gene therapy.
Por: Kuiper, M, et al.
Publicado em: (1996)

An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemia.
Por: Chan, L, et al.
Publicado em: (2006)

IL-2/B7.1 fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: A strategy to generate whole cell vaccines for AML
Por: Chan, L, et al.
Publicado em: (2004)

Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
Por: Galea-Lauri, J, et al.
Publicado em: (1999)

IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
Por: Chan, L, et al.
Publicado em: (2005)

Dendritic cell/tumour fusions are more efficient at eliciting MHC class I-restricted Ag-specific CTL responses when compared to antigen-pulsed dendritic cells
Por: Galea-Lauri, J, et al.
Publicado em: (2001)

Low-speed centrifugation of retroviral vectors absorbed to a particulate substrate: a highly effective means of enhancing retroviral titre.
Por: Darling, D, et al.
Publicado em: (2000)

Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis
Por: Shu-Yi Yin, et al.
Publicado em: (2016-04-01)

Fusagene vectors: A novel strategy for the expression of multiple genes from a single cistron
Por: Gaken, J, et al.
Publicado em: (1998)

Erratum: Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis
Por: Shu-Yi Yin, et al.
Publicado em: (2016-06-01)

Novel costimulators in the immune gene therapy of cancer.
Por: Galea-Lauri, J, et al.
Publicado em: (1996)

Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cells.
Por: Chan, L, et al.
Publicado em: (2005)

Prospects of immune gene therapy for cancer
Por: Hardwick, N, et al.
Publicado em: (2004)

Tumour immune rejection triggered by activation of α2-adrenergic receptors
Por: Zhu, J, et al.
Publicado em: (2023)

Fas Ligand breaks tolerance to self antigens, induces tumour immunity and helps to generate tumour-rejecting monoclonal antibodies
Por: Simon, A, et al.
Publicado em: (2005)

Monocistronic high titre vectors for targeted expression of multiple therapeutic genes
Por: Darling, D, et al.
Publicado em: (2004)

High titre vectors for targeted expression of multiple genes
Por: Darling, D, et al.
Publicado em: (2004)

Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination.
Por: Galea-Lauri, J, et al.
Publicado em: (2002)

Surface enhanced deep Raman detection of cancer tumour through 71 mm of heterogeneous tissue
Por: Dey, P, et al.
Publicado em: (2022)

A comparison of CTL induction by different methods of antigen loading of monocyte-derived dendritic cells
Por: Galea-Lauri, J, et al.
Publicado em: (2001)

Harnessing the immune system to reject cancers through genetic modifications of tumour cells
Por: Ajzensztejn, D
Publicado em: (2015)

Advances in IL-7 Research on Tumour Therapy
Por: Chunxue Fu, et al.
Publicado em: (2024-03-01)

Induction with Varied Histological Patterns in Adenomatoid Odontogenic Tumour
Por: Nawal Khan, et al.
Publicado em: (2017-07-01)

Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces
Por: Sabina Sangaletti, et al.
Publicado em: (2020-11-01)

Interleukin 1 (IL-1) and tumour necrosis factor synergise in the induction of IL-1 synthesis by human vascular endothelial cells.
Por: Howells, G, et al.
Publicado em: (1988)

Tumour markers in pediatric solid tumours
Por: Singal A, et al.
Publicado em: (2005-01-01)

Tumours and Tumour - Like Lesions of Scapula
Por: Jindra Brtková, et al.
Publicado em: (1999-01-01)

Tumour volume distribution can yield information on tumour growth and tumour control
Por: Uwe Schneider, et al.
Publicado em: (2022-05-01)

Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron.
Por: Gäken, J, et al.
Publicado em: (2000)

Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron
Por: Gaken, J, et al.
Publicado em: (2001)

Induction Therapy Followed by Surgery for Unresectable Thymic Epithelial Tumours
Por: Shuai Wang, et al.
Publicado em: (2022-01-01)

Generation of tumour-rejecting anti-carbohydrate monoclonal antibodies using melanoma modified with Fas ligand.
Por: Simon, A, et al.
Publicado em: (2008)

Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours
Por: Kamilla JA. Bigos, et al.
Publicado em: (2024-01-01)

The relationship between IL-6 and thrombocytosis accompanying gastrointestinal tumours
Por: Valéria Jósa, et al.
Publicado em: (2020-09-01)

IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours
Por: Hyungseok Seo, et al.
Publicado em: (2017-06-01)

An epidemiological survey of tumour or tumour like conditions in the scapula and periscapular region
Por: Khan Zeeshan, et al.
Publicado em: (2016-01-01)